Lupin, the world's seventh-largest generic drugmaker, said North America sales rose 73.1 percent to about 20 billion rupees
Read More
The two companies, which have co-developed insulin glargine, said they look forward to offering another insulin treatment option for diabetic patients
Read More
Online pharmacy business is going on illegally and government authorities are not taking any action, says All India Organisation of Chemists and Druggists
Read More
K. Anand, CEO and managing director, Qualiminds, tells BW Businessworld that the pharmaceutical industry’s attitude to compliance with regulatory norms has to change
Read More
Indian pharma companies have had to pay a heavy cost for non-compliance with US FDA regulations and post-ban remedial measures using pricey foreign consultants unfamiliar with the country. Now, help is available locally and at a much cheaper cost
Read More
As per Sebi guidelines, 15 per cent of the buyback offer is reserved for shareholders holding shares having a market value of not more than Rs 2,00,000 as on the record date
Read More
The deal, which has been signed for an undisclosed valuation, will include the products and technology as well as manufacturing facilities and people
Read More
With the introduction of a new regulatory policy in India and increased affordability that biosimilars offer, the domestic market is expected to grow at an accelerated pace
Read More
